Advertisement
UK markets closed

  • NIKKEI 225

    38,835.10
    +599.03 (+1.57%)
     

  • HANG SENG

    18,479.37
    -98.93 (-0.53%)
     

  • CRUDE OIL

    78.50
    +0.02 (+0.03%)
     

  • GOLD FUTURES

    2,320.90
    -10.30 (-0.44%)
     

  • DOW

    38,887.13
    +34.86 (+0.09%)
     

  • Bitcoin GBP

    50,466.17
    +165.57 (+0.33%)
     

  • CMC Crypto 200

    1,308.11
    -57.01 (-4.17%)
     

  • NASDAQ Composite

    16,327.70
    -21.55 (-0.13%)
     

  • UK FTSE All Share

    4,522.99
    +53.90 (+1.21%)
     
Money:

The retirement income gap no-one is talking about

People are living longer than ever before and this can impact how you plan for retirement

Outlook on the Artificial Tears Global Market to 2028 - by Type, Delivery Mode, Application and Geography

Research and Markets
·8-min read

Dublin, July 12, 2021 (GLOBE NEWSWIRE) -- The "Artificial Tears Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Type, Delivery Mode, and Application" report has been added to ResearchAndMarkets.com's offering.

The artificial tears market was valued at US$ 2,612.91 million in 2020 and is projected to reach US$ 3,961.63 million by 2028; it is expected to grow at a CAGR of 5.34% during 2020-2028. The factors such as rising dry eye incidence and surging older population fuel the market growth. Moreover, increasing number of industrial developments is expected to foster the market growth during the forecast period. However, the poor accessibility to eye care services in low-income countries hinders the growth of the artificial tears market.

APAC countries are witnessing drop in the demand for artificial tears products. The COVID-19 outbreak has disrupted supply chain. Moreover, low-income countries face additional challenges due to the shortage of healthcare infrastructure. Restrictive measures have been put forth in South Korea, Malaysia, Singapore, the Philippines, and India to prevent the transmission of novel coronavirus that causes COVID-19. The market is witnessing demand in artificial tear drops owing to increasing use of electronic devices.

The global artificial tears market is segmented on the bases of type, delivery mode, and application. Based on type, the market is segmented into cellulose derived tears, glycerin derived tears, oil-based emulsion tears, polythylene glycol-based tears, propylene glycol-based tears, and sodium hyaluronate based artificial tears. The glycerin derived tears segment held the largest share of the market in 2020 and is anticipated to register the highest CAGR during 2021-2028. By delivery mode, the market is bifurcated into eye drops and ointments. The eye drops segment held a larger market share in 2020, and the same segment is estimated to register a higher CAGR during the forecast period. The artificial tears market, based on application, is bifurcated into dry eyes treatment and contact lenses moisture. The dry eyes treatment segment held a larger share of the market in 2020 and is estimated to register a higher CAGR from 2021 to 2028.

Reasons to Buy

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the artificial tears market.

  • Highlights key business priorities in order to assist companies to realign their business strategies.

  • The key findings and recommendations highlight crucial progressive industry trends in the global artificial tears market, thereby allowing players across the value chain to develop effective long-term strategies.

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Key Topics Covered:

1. Introduction

2. Artificial Tears Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Artificial Tears Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinions

5. Artificial Tears Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Incidence of Dry Eye
5.1.2 Growing Older Population
5.2 Market Restraints
5.2.1 Poor Accessibility to Eye Care Services in Low-Income Countries
5.3 Market Opportunities
5.3.1 Increasing Number of Industrial Developments
5.4 Future Trends
5.4.1 Changes in Lifestyle
5.5 Impact Analysis

6. Artificial Tears Market - Global Analysis
6.1 Global Artificial Tears Market Revenue Forecast and Analysis
6.2 Global Artificial Tears Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players

7. Artificial Tears Market Analysis - By Type
7.1 Overview
7.2 Artificial Tears Market Revenue Share, by Type (2020 and 2028)
7.3 Cellulose Derived Tears
7.3.1 Overview
7.3.2 Cellulose Derived Tears: Artificial Tears Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Glycerin Derived Tears
7.4.1 Overview
7.4.2 Glycerin Derived Tears: Artificial Tears Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Oil-based Emulsion Tears
7.5.1 Overview
7.5.2 Oil-based Emulsion Tears: Artificial Tears Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Polyethylene Glycol Based Tears
7.6.1 Overview
7.6.2 Polyethylene Glycol Based Tears: Artificial Tears Market - Revenue and Forecast to 2028 (US$ Million)
7.7 Propylene Glycol Based Tears
7.7.1 Overview
7.7.2 Propylene Glycol Based Tears: Artificial Tears Market - Revenue and Forecast to 2028 (US$ Million)
7.8 Sodium Hyaluronate Based Artificial Tears
7.8.1 Overview
7.8.2 Sodium Hyaluronate Based Artificial Tears: Artificial Tears Market - Revenue and Forecast to 2028 (US$ Million)

8. Artificial Tears Market Analysis - By Delivery Mode
8.1 Overview
8.2 Artificial Tears Market Revenue Share, by Delivery Mode (2020 and 2028)
8.3 Eye Drops
8.3.1 Overview
8.3.2 Eye Drops: Artificial Tears Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Ointments
8.4.1 Overview
8.4.2 Ointments: Artificial Tears Market - Revenue and Forecast to 2028 (US$ Million)

9. Artificial Tears Market Analysis - By Application
9.1 Overview
9.2 Artificial Tears Market Share, by Application, 2020 and 2028, (%)
9.3 Dry Eyes Treatment
9.3.1 Overview
9.3.2 Dry Eyes Treatment: Artificial Tears Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Contact Lenses Moisture
9.4.1 Overview
9.4.2 Contact Lenses Moisture: Artificial Tears Market - Revenue and Forecast to 2028 (US$ Million)

10. Artificial Tears Market - Geographic Analysis

11. Impact of COVID-19 Pandemic on Global Artificial Tears Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
11.5 South and Central America: Impact Assessment of COVID-19 Pandemic

12. Artificial Tears Market- Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview

13. Company Profiles
13.1 Johnson and Johnson Services, Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Alcon Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 OASIS Medical
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Abbvie Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Bayer AG
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Prestige Consumer Healthcare Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Santen Pharmaceutical Co., Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Bausch Health Companies Inc.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Akorn, Incorporated
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Aurolab
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix

For more information about this report visit https://www.researchandmarkets.com/r/l76idu

ADVERTISEMENT
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900